home / stock / itos / itos quote
Last: | $10.80 |
---|---|
Change Percent: | 0.09% |
Open: | $10.59 |
Close: | $10.80 |
High: | $10.9 |
Low: | $10.55 |
Volume: | 140,901 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$10.8 | $10.59 | $10.8 | $10.9 | $10.55 | 140,901 | 04-26-2024 |
$10.6 | $10.48 | $10.6 | $10.62 | $10.26 | 171,996 | 04-25-2024 |
$10.57 | $11 | $10.57 | $11.22 | $10.56 | 148,466 | 04-24-2024 |
$10.99 | $10.8 | $10.99 | $11.1 | $10.76 | 300,673 | 04-23-2024 |
$10.79 | $10.65 | $10.79 | $11.16 | $10.45 | 182,392 | 04-22-2024 |
$10.56 | $10.27 | $10.56 | $10.61 | $10.01 | 943,393 | 04-19-2024 |
$10.33 | $10.62 | $10.33 | $10.625 | $10.24 | 209,155 | 04-18-2024 |
$10.68 | $11.15 | $10.68 | $11.215 | $10.62 | 198,768 | 04-17-2024 |
$11.1 | $11.69 | $11.1 | $11.75 | $11.06 | 122,679 | 04-16-2024 |
$11.76 | $11.78 | $11.76 | $11.99 | $11.62 | 129,928 | 04-15-2024 |
$11.72 | $12.22 | $11.72 | $12.37 | $11.57 | 133,271 | 04-12-2024 |
$12.3 | $12.31 | $12.3 | $12.46 | $12.15 | 107,104 | 04-11-2024 |
$12.24 | $12.32 | $12.24 | $12.37 | $11.93 | 194,373 | 04-10-2024 |
$12.65 | $12.23 | $12.65 | $13.35 | $12.23 | 189,001 | 04-09-2024 |
$12.22 | $12.38 | $12.22 | $12.66 | $12.18 | 191,663 | 04-08-2024 |
$12.36 | $12.36 | $12.36 | $12.55 | $12.21 | 145,216 | 04-05-2024 |
$12.44 | $13.23 | $12.44 | $13.2999 | $12.35 | 235,325 | 04-04-2024 |
$13.12 | $12.66 | $13.12 | $13.27 | $12.54 | 918,195 | 04-03-2024 |
$12.68 | $13.16 | $12.68 | $13.16 | $12.53 | 460,414 | 04-02-2024 |
$13.34 | $13.8 | $13.34 | $13.8 | $13.27 | 324,811 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
iTeos Therapeutics Inc. Company Name:
ITOS Stock Symbol:
NASDAQ Market:
WATERTOWN, Mass. and GOSSELIES, Belgium, April 07, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients, today announced a poster prese...
2024-04-02 17:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
WATERTOWN, Mass. and GOSSELIES, Belgium, March 06, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (NASDAQ:ITOS), a clinical-stage biopharmace...